111 related articles for article (PubMed ID: 21684039)
1. Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice.
Tozzi A; Costa C; Siliquini S; Tantucci M; Picconi B; Kurz A; Gispert S; Auburger G; Calabresi P
Neurobiol Aging; 2012 Aug; 33(8):1792-9. PubMed ID: 21684039
[TBL] [Abstract][Full Text] [Related]
2. A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.
Kurz A; Double KL; Lastres-Becker I; Tozzi A; Tantucci M; Bockhart V; Bonin M; García-Arencibia M; Nuber S; Schlaudraff F; Liss B; Fernández-Ruiz J; Gerlach M; Wüllner U; Lüddens H; Calabresi P; Auburger G; Gispert S
PLoS One; 2010 Jul; 5(7):e11464. PubMed ID: 20628651
[TBL] [Abstract][Full Text] [Related]
3. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
Peneder TM; Scholze P; Berger ML; Reither H; Heinze G; Bertl J; Bauer J; Richfield EK; Hornykiewicz O; Pifl C
Neuroscience; 2011 Apr; 180():280-92. PubMed ID: 21333719
[TBL] [Abstract][Full Text] [Related]
4. Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains.
Piltonen M; Savolainen M; Patrikainen S; Baekelandt V; Myöhänen TT; Männistö PT
Neuroscience; 2013 Feb; 231():157-68. PubMed ID: 23219665
[TBL] [Abstract][Full Text] [Related]
5. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice.
Unger EL; Eve DJ; Perez XA; Reichenbach DK; Xu Y; Lee MK; Andrews AM
Neurobiol Dis; 2006 Feb; 21(2):431-43. PubMed ID: 16230020
[TBL] [Abstract][Full Text] [Related]
6. Synaptic dysfunction in Parkinson's disease.
Picconi B; Piccoli G; Calabresi P
Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
[TBL] [Abstract][Full Text] [Related]
7. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.
Kitada T; Pisani A; Porter DR; Yamaguchi H; Tscherter A; Martella G; Bonsi P; Zhang C; Pothos EN; Shen J
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11441-6. PubMed ID: 17563363
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
[TBL] [Abstract][Full Text] [Related]
9. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
[TBL] [Abstract][Full Text] [Related]
10. Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein.
Watson JB; Hatami A; David H; Masliah E; Roberts K; Evans CE; Levine MS
Neuroscience; 2009 Mar; 159(2):501-13. PubMed ID: 19361478
[TBL] [Abstract][Full Text] [Related]
11. Striatal dopamine transmission is subtly modified in human A53Tα-synuclein overexpressing mice.
Platt NJ; Gispert S; Auburger G; Cragg SJ
PLoS One; 2012; 7(5):e36397. PubMed ID: 22570709
[TBL] [Abstract][Full Text] [Related]
12. Synaptic dysfunction in Parkinson's disease.
Bagetta V; Ghiglieri V; Sgobio C; Calabresi P; Picconi B
Biochem Soc Trans; 2010 Apr; 38(2):493-7. PubMed ID: 20298209
[TBL] [Abstract][Full Text] [Related]
13. Selective noradrenergic vulnerability in α-synuclein transgenic mice.
Sotiriou E; Vassilatis DK; Vila M; Stefanis L
Neurobiol Aging; 2010 Dec; 31(12):2103-14. PubMed ID: 19152986
[TBL] [Abstract][Full Text] [Related]
14. Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons.
Cabeza-Arvelaiz Y; Fleming SM; Richter F; Masliah E; Chesselet MF; Schiestl RH
Mol Neurodegener; 2011 Dec; 6():83. PubMed ID: 22165993
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in mice.
Plaas M; Karis A; Innos J; Rebane E; Baekelandt V; Vaarmann A; Luuk H; Vasar E; Koks S
J Physiol Pharmacol; 2008 Jun; 59(2):205-16. PubMed ID: 18622040
[TBL] [Abstract][Full Text] [Related]
17. Sub-regional differences and mechanisms of the short-term plasticity of dopamine overflow in striatum in mice lacking alpha-synuclein.
Chadchankar H; Yavich L
Brain Res; 2011 Nov; 1423():67-76. PubMed ID: 22000591
[TBL] [Abstract][Full Text] [Related]
18. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
Errico F; Bonito-Oliva A; Bagetta V; Vitucci D; Romano R; Zianni E; Napolitano F; Marinucci S; Di Luca M; Calabresi P; Fisone G; Carta M; Picconi B; Gardoni F; Usiello A
Exp Neurol; 2011 Dec; 232(2):240-50. PubMed ID: 21946266
[TBL] [Abstract][Full Text] [Related]
19. Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation.
Geracitano R; Paolucci E; Prisco S; Guatteo E; Zona C; Longone P; Ammassari-Teule M; Bernardi G; Berretta N; Mercuri NB
Neuroscience; 2003; 118(2):399-408. PubMed ID: 12699776
[TBL] [Abstract][Full Text] [Related]
20. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
Cabin DE; Gispert-Sanchez S; Murphy D; Auburger G; Myers RR; Nussbaum RL
Neurobiol Aging; 2005 Jan; 26(1):25-35. PubMed ID: 15585343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
